Anti-ICAM-1 monoclonal antibody YN1/1.7.4

Drug Profile

Anti-ICAM-1 monoclonal antibody YN1/1.7.4

Alternative Names: YN1/1.7; YNI/1.7

Latest Information Update: 01 Sep 1998

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer Isis Pharmaceuticals; Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action Intercellular adhesion molecule 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Transplant rejection

Most Recent Events

  • 01 Sep 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)
  • 01 Sep 1998 No-Development-Reported for Transplant rejection in USA (Unknown route)
  • 04 Nov 1996 A study has been added to the Transplant Rejection pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top